Growth Opportunities in Humanized Mouse Model Market Humanized Mouse Model Market | Page 2

The cell-based humanized mouse models segment is further categorized into CD34, PBMC, and
BLT humanized mouse models. In 2017, the CD34 models segment commanded the largest
share of the cell-based humanized mouse models market and is expected to grow at the
highest CAGR during the forecast period.
Contract Research Organizations (CROs) to dominate the humanized mouse models market
during the forecast period
By end user, the humanized mouse models market is categorized into pharmaceutical &
biotechnology companies, contract research organizations (CRO), and academic & research
institutions. The contract research organizations (CROs) segment is projected to grow at the
highest CAGR during the forecast period. Growth in this segment is largely due to the increasing
number of pharmaceutical companies outsourcing their preclinical studies to contract research
organizations (CROs).
North America dominated the market in 2017
North America dominated the global humanized mouse models market in 2017. Growth in this
regional segment can be attributed to the increasing monoclonal antibody production,
preclinical activities by CROs and pharmaceutical R&D, continued and responsible use of
animals ensured by animal care organizations, growing biomedical research in the US along
with government support for the development of protein drugs, and growing stem cell research
in Canada.
Read More About Humanized Mouse and Rat Model Market:
https://www.marketsandmarkets.com/PressReleases/humanized-mouse-model.asp
The major market players in the humanized mouse models market include The Jackson
Laboratory (US), Taconic Biosciences, Inc. (US), Horizon Discovery Group plc (UK), genOway,
S.A. (France), Charles River Laboratories (US), Harbour Antibodies BV (China), Hera BioLabs
(US), Vitalstar Biotechnology Co., Ltd. (China), inGenious Targeting Laboratory (US), AXENIS
S.A.S (France), Crown Bioscience, Inc. (US), Transgenic, Inc. (Japan), and Champions Oncology,
Inc. (US). The major players in the humanized rat models market include Horizon Discovery
Group plc (UK), Hera BioLabs (US), and Yecuris Corporation (US).
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche
opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.
Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies
as clients. Almost 75,000 top officers across eight industries worldwide approach
MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth
markets following the "Growth Engagement Model – GEM". The GEM aims at proactive
collaboration with the clients to identify new opportunities, identify most important customers,
write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both
the company and its competitors. MarketsandMarkets™ now coming up with 1,500
MicroQuadrants (Positioning top players across leaders, emerging companies, innovators,